These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1095 related items for PubMed ID: 15802030

  • 1. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K.
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [Abstract] [Full Text] [Related]

  • 2. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K, Bindra R, Cacho AM, Nicolaides KH.
    Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
    [Abstract] [Full Text] [Related]

  • 3. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.
    Bestwick JP, Huttly WJ, Wald NJ.
    J Med Screen; 2008 Mar; 15(4):204-6. PubMed ID: 19106261
    [Abstract] [Full Text] [Related]

  • 4. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS, Nasrat HA, Rouzi AA, Qari MH, Al-Qahtani MH, Abuzenadah AM.
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [Abstract] [Full Text] [Related]

  • 5. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [Abstract] [Full Text] [Related]

  • 6. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium.
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [Abstract] [Full Text] [Related]

  • 7. [Effect of maternal smoking on concentrations of the pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of chorionic gonadotropin (beta hCG) in the first trimester of pregnancy].
    Gajewska J, Ceran A, Chełchowska M, Borowski D, Ambroszkiewicz J, Jaczyńska R, Zwoliński J, Laskowska-Klita T.
    Przegl Lek; 2008 Nov; 65(10):479-82. PubMed ID: 19189527
    [Abstract] [Full Text] [Related]

  • 8. Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
    Spencer K, Crossley JA, Aitken DA, Nicolaides KH.
    Prenat Diagn; 2005 May; 25(5):358-61. PubMed ID: 15906423
    [Abstract] [Full Text] [Related]

  • 9. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [Abstract] [Full Text] [Related]

  • 10. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
    Spencer K, Cowans NJ, Avgidou K, Nicolaides KH.
    Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
    [Abstract] [Full Text] [Related]

  • 11. Increased time-to-pregnancy and first trimester Down's syndrome screening.
    Ranta JK, Raatikainen K, Romppanen J, Pulkki K, Heinonen S.
    Hum Reprod; 2010 Feb; 25(2):412-7. PubMed ID: 19945962
    [Abstract] [Full Text] [Related]

  • 12. Does vaginal bleeding influence first-trimester markers for Down syndrome?
    Heinig J, Steinhard J, Schmitz R, Nofer JR, Witteler R, Mosel A, Ahrens A, Kiesel L, Klockenbusch W.
    Prenat Diagn; 2007 Apr; 27(4):312-6. PubMed ID: 17286311
    [Abstract] [Full Text] [Related]

  • 13. [Screening by maternal serum markers for Down's syndrome].
    Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, Bian XM, Yang JQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [Abstract] [Full Text] [Related]

  • 14. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program.
    Krantz DA, Hallahan TW, Macri VJ, Macri JN.
    Prenat Diagn; 2005 Aug; 25(8):635-40. PubMed ID: 16049986
    [Abstract] [Full Text] [Related]

  • 15. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus.
    Savvidou MD, Syngelaki A, Muhaisen M, Emelyanenko E, Nicolaides KH.
    BJOG; 2012 Mar; 119(4):410-6. PubMed ID: 22324916
    [Abstract] [Full Text] [Related]

  • 16. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy.
    Spencer K, Bindra R, Nicolaides KH.
    Prenat Diagn; 2003 Oct; 23(10):851-5. PubMed ID: 14558032
    [Abstract] [Full Text] [Related]

  • 17. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers.
    Spencer K, Kagan KO, Nicolaides KH.
    Prenat Diagn; 2008 Jan; 28(1):49-52. PubMed ID: 18186136
    [Abstract] [Full Text] [Related]

  • 18. First trimester Down syndrome screening: distribution of markers and comparison of assays for quantification of pregnancy-associated plasma protein-A.
    Wøjdemann KR, Larsen SO, Rode L, Shalmi A, Sundberg K, Christiansen M, Tabor A.
    Scand J Clin Lab Invest; 2006 Jan; 66(2):101-11. PubMed ID: 16537243
    [Abstract] [Full Text] [Related]

  • 19. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
    Talbot JA, Spencer K, Abushoufa RA.
    Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
    [Abstract] [Full Text] [Related]

  • 20. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
    Spencer K, Aitken DA, Macri JN, Buchanan PD.
    Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.